Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
24.50
+0.70 (2.94%)
At close: May 1, 2026, 4:00 PM EDT
24.49
-0.01 (-0.04%)
After-hours: May 1, 2026, 7:15 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $882.45 million as of May 1, 2026.
Market Cap
882.45M
Enterprise Value
735.31M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.50
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $882.45M, an increase of 83.37%. That is a compound annual growth rate of 251.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 882.45M | 63.51% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 909.96M |
| SELLAS Life Sciences Group | 909.75M |
| LB Pharmaceuticals | 901.28M |
| Sana Biotechnology | 882.87M |
| MannKind | 876.98M |
| Alto Neuroscience | 874.22M |
| Janux Therapeutics | 872.33M |
| MeiraGTx Holdings | 870.96M |